×
About 23,300 results

ALLMedicine™ Rhinitis Center

Research & Reviews  5,966 results

Montelukast as a potential treatment for COVID-19.
https://doi.org/10.1080/14656566.2023.2192866
Expert Opinion on Pharmacotherapy; McCarthy MW

Mar 18th, 2023 - : Montelukast is a leukotriene inhibitor that is widely used to treat chronic asthma and allergic rhinitis. The drug interferes with molecular signaling pathways produced by leukotrienes in a variety of cells and tissues throughout the human body ...

Safety and Performance Assessment of the Decongestant Seawater Spray Pocket Valve Enriched With Essential Oils in Patients With Acute Rhinitis Associated With Nasal Obstruction
https://clinicaltrials.gov/ct2/show/NCT05494346

Mar 17th, 2023 - The purpose of this pre-market clinical investigation is to assess the safety and the performance of decongestant seawater spray pocket valve enriched with essential oils by Gilbert Laboratories. The study will evaluate the results of acute rhinit...

House Dust Mite Sublingual Immunotherapy Tablet Safety in Adolescents with Allergic Rhi...
https://doi.org/10.1016/j.anai.2023.03.006
Annals of Allergy, Asthma & Immunology : Official Publica... Horn A, Bernstein DI et. al.

Mar 17th, 2023 - The HDM sublingual immunotherapy (SLIT)-tablet is a treatment option for allergic rhinitis with/without conjunctivitis (AR/C) approved in adults worldwide and in adolescents in some countries. The MT-18 trial was conducted in adolescents to supple...

MiR-223-3p regulates the eosinophil degranulation and enhances the inflammation in alle...
https://doi.org/10.1016/j.intimp.2023.110007
International Immunopharmacology; Wu S, Wang Z et. al.

Mar 17th, 2023 - MiR-223-3p is a multifunctional microRNA regulated by multiple transcription factors and plays a critical role in inflammation. This paper was designed to investigate the regulatory role and mechanism of miR-223-3p in eosinophils degranulation and...

Probiotic treatment (enterococcus faecalis) improves symptoms of seasonal allergic rhin...
https://doi.org/10.1002/alr.23154
International Forum of Allergy & Rhinology; Schaefer M, Zimmermann K et. al.

Mar 16th, 2023 - Probiotic treatment (enterococcus faecalis) improves symptoms of seasonal allergic rhinitis: a randomized controlled trial.|2023|Schaefer M,Zimmermann K,Enck P,|

see more →

Guidelines  10 results

Screening for Lung Cancer
https://www.aafp.org/afp/2021/0700/p79.html
American Family Physician; Tracer H, Pierre J.

Jul 7th, 2021 - S.J., a 68-year-old Black man, comes to your office to establish care after recently moving to the area. S.J. has a history of allergic rhinitis, osteoarthritis, and gastroesophageal reflux disease. Additionally, he has a 39-pack-year history of s...

European Position Paper on Rhinosinusitis and Nasal Polyps 2020.
https://doi.org/10.4193/Rhin20.600
Rhinology Fokkens WJ, Lund VJ et. al.

Feb 23rd, 2020 - The European Position Paper on Rhinosinusitis and Nasal Polyps 2020 is the update of similar evidence based position papers published in 2005 and 2007 and 2012. The core objective of the EPOS2020 guideline is to provide revised, up-to-date and cle...

Clinical practice guidelines for the management of olfactory dysfunction - Secondary pu...
https://doi.org/10.1016/j.anl.2019.04.002
Auris, Nasus, Larynx; Miwa T, Ikeda K et. al.

May 12th, 2019 - To provide an evidence-based recommendation for the management of olfactory dysfunction in accordance with the consensus reached by the Subcommittee of the Japanese Clinical Practice Guideline for olfactory dysfunction in the Japanese Rhinologic S...

Pharmacologic Treatment of Seasonal Allergic Rhinitis: Synopsis of Guidance From the 20...
https://doi.org/10.7326/M17-2203
Annals of Internal Medicine; Wallace DV, Dykewicz MS et. al.

Nov 29th, 2017 - The Joint Task Force on Practice Parameters, which comprises representatives of the American Academy of Allergy, Asthma and Immunology (AAAAI) and the American College of Allergy, Asthma and Immunology (ACAAI), formed a workgroup to review evidenc...

Allergic Rhinitis and its Impact on Asthma (ARIA) guidelines-2016 revision.
https://doi.org/10.1016/j.jaci.2017.03.050
The Journal of Allergy and Clinical Immunology; Brożek JL, Bousquet J et. al.

Jun 13th, 2017 - Allergic rhinitis (AR) affects 10% to 40% of the population. It reduces quality of life and school and work performance and is a frequent reason for office visits in general practice. Medical costs are large, but avoidable costs associated with lo...

see more →

Drugs  1,718 results see all →

Clinicaltrials.gov  1,031 results

Safety and Performance Assessment of the Decongestant Seawater Spray Pocket Valve Enriched With Essential Oils in Patients With Acute Rhinitis Associated With Nasal Obstruction
https://clinicaltrials.gov/ct2/show/NCT05494346

Mar 17th, 2023 - The purpose of this pre-market clinical investigation is to assess the safety and the performance of decongestant seawater spray pocket valve enriched with essential oils by Gilbert Laboratories. The study will evaluate the results of acute rhinit...

Integrative Omics Approach to Allergic Rhinitis
https://clinicaltrials.gov/ct2/show/NCT03324100

Mar 10th, 2023 - Nasal mucus and nasal epithelium are the first defense barriers against allergens. Various proteins are found in nasal mucus that play a role in allergic rhinitis and reflect immune response to allergen exposure. The difference in the proteomic pr...

Symbiofilm Trial in Allergic Kids (SYMBIOFILM-TAK)
https://clinicaltrials.gov/ct2/show/NCT05034328

Mar 10th, 2023 - Healsea® Children is a seawater-based nasal spray supplemented with a natural Symbiofilm® extract (0.02%) isolated from marine bacteria. Symbiofilm® is an exopolymeric composition with emulsifying properties, in vitro antibiofilm activity and deta...

Nasal Mucus Proteome and Immunotherapy
https://clinicaltrials.gov/ct2/show/NCT02159404

Mar 10th, 2023 - Nasal mucus as first line defense barrier of the nasal mucosa contains a variety of proteins that act as functional units. We recently showed that the nasal mucus proteome between allergic rhinitis patients and healthy controls is significantly al...

Severe Eosinophilic Asthma Phenotypes During Childhood Have Various Origins
https://clinicaltrials.gov/ct2/show/NCT05762627

Mar 9th, 2023 - Multiple sensitizations but also blood eosinophilia are associated with the persistence of exacerbations during childhood. The pivotal role of eosinophilia in the pathophysiology of allergic asthma and more generally of severe asthma in the pediat...

see more →

News  555 results

Long-Term Exposure to Extreme Temps Tied to Newborn Lung Function
https://www.medpagetoday.com/pulmonology/generalpulmonary/103598

Mar 17th, 2023 - Long-term exposure to heat and cold from the second trimester to 4 weeks after birth was associated with lung function among female newborns, according to a French population-based cohort study. Specifically, long-term heat and cold exposure were ...

In utero exposure to asthma medication not tied to risks of neurodevelopmental disorders
https://www.mdedge.com/familymedicine/article/261721/pediatrics/utero-exposure-asthma-medication-not-tied-risks
MDedge Family Medicine; Heidi Splete

Mar 9th, 2023 - Use of asthma medication by pregnant women was not associated with an increased risk of autism, attention-deficit/hyperactivity disorder, or Tourette syndrome for their children, a new study shows. The drugs included in the study were leukotriene-.

Study Reassures on Asthma Med Use in Pregnancy and Kids' Neuropsych Risks
https://www.medpagetoday.com/allergyimmunology/asthma/103424

Mar 7th, 2023 - Use of leukotriene-receptor antagonists (LTRAs) during pregnancy was not associated with significant risks of neuropsychiatric events in offspring, according to a nationwide cohort study from Taiwan. Among the children of women with a diagnosis of...

Evaluating and Treating Children With Long COVID
https://www.medpagetoday.com/infectiousdisease/longcovid/103300

Feb 27th, 2023 - Experts shared advice on diagnosis and treatment of children and adolescents showing signs of post-COVID conditions -- also known as long COVID -- during a CDC Clinician Outreach and Communication Activity (COCA) webinar. "Post-COVID conditions" i...

Sublingual Immunotherapy Appears Viable in Treating Peanut Allergies in Kids
https://www.medpagetoday.com/allergyimmunology/allergy/103271

Feb 24th, 2023 - Peanut sublingual immunotherapy (SLIT) achieved clinically significant desensitization to peanut allergens in the majority of children in an open-label, prospective study. Among 47 kids who completed therapy and the 48-month double-blind, placebo-...

see more →

Patient Education  40 results see all →